The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers.

doi:10.1111/bju.16432

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers.

BJU international - 1 Sept 2024

Bancroft Elizabeth K, Page Elizabeth C, Brook Mark N, Pope Jennifer, Thomas Sarah, Myhill Kathryn, Helfand Brian T, Talaty Pooja, Ong Kai-Ren, Douglas Emma, Cook Jackie, Rosario Derek J, Salinas Monica, Buys Saundra S, Anson Jo, Davidson Rosemarie, Longmuir Mark, Side Lucy, Eccles Diana M, Tischkowitz Marc, Taylor Amy, Cruellas Mara, Ballestero Eduard Perez, Cleaver Ruth, Varughese Mohini, Barwell Julian, LeButt Mandy, Greenhalgh Lynn, Hart Rachel, Azzabi Ashraf, Jobson Irene, Cogley Lynn, Evans D Gareth, Rothwell Jeanette, Taylor Natalie, Hogben Matthew, Saya Sibel, Eeles Rosalind A, Aaronson Neil K

Abstract excerpt

OBJECTIVES: To report the long-term outcomes from a longitudinal psychosocial study that forms part of the 'Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted Screening in men at higher genetic risk and controls' (IMPACT) study. The IMPACT study is a multi-national study of targeted prostate cancer (PrCa) screening in individuals with a known germline pathogenic variant (GPV) in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anxiety

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Early Detection of Cancer

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Longitudinal Studies

Share to Prostatic Neoplasms

Share to Quality of Life

Share to Surveys and Questionnaires

Source

Open in PubMed

Identifiers

PMID: 38839570
DOI: 10.1111/bju.16432

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers.PMID 38839570Read ↗

Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations.Semantic proximity Read ↗

The psychological impact of undergoing genetic-risk profiling in men with a family history of prostate cancer.Semantic proximity Read ↗

Psychosocial outcomes of risk-adapted prevention for prostate cancer predisposition: study protocol for a longitudinal observational mixed-methods study.Semantic proximity Read ↗

Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.Semantic proximity Read ↗

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study.Semantic proximity Read ↗

Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.Semantic proximity Read ↗

Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer.Semantic proximity Read ↗

Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort.Semantic proximity Read ↗

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation CarriersSemantic proximity Read ↗

Influence of family history on psychosocial distress and perceived need for treatment in prostate cancer survivors.Semantic proximity Read ↗

Impact of rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis on psychosocial functioning.Semantic proximity Read ↗

Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.